OncoMatch/Clinical Trials/NCT07636200
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Is NCT07636200 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for advanced solid tumor cancer.
Check if I qualifyExtracted eligibility criteria
Cancer type
Tumor Agnostic
Glioblastoma
Ovarian Cancer
Small Cell Lung Cancer
Disease stage
Required: Stage IV, III
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- University of Colorado Anschutz Medical Campus · Aurora, Colorado
- University of Colorado Boulder · Boulder, Colorado
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07636200 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage IV or III is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages